Study to Evaluate the Effects of AZD3427 in Patients with Heart Failure

Trial Identifier:	D8330C00002
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT04890548
Start Date:	November 2021
Primary Completion Date:	August 2022
Condition:	Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Cambridge, United Kingdom, CB2 0QQ
United Kingdom	London, United Kingdom, W1N 8AA

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.